Jim Simons’s ARK Genomic Revolution ETF ARKG Stock Holding History

Jim Simons’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-67,700	Closed	-$1.96M	–	3242
2025 Q4	$1.96M	Sell	67,700 -15,600	-19%	-$468K	﹤0.01%	1883
2025 Q3	$2.31M	Buy	+83,300	New	+$2.1M	﹤0.01%	1974
2022 Q4	–	Sell	-17,800	Closed	-$585K	–	4098
2022 Q3	$585K	Buy	+17,800	New	+$653K	﹤0.01%	2833
2022 Q2	–	Sell	-57,600	Closed	-$2.65M	–	4201
2022 Q1	$2.65M	Buy	57,600 +16,200	+39%	+$772K	﹤0.01%	2011
2021 Q4	$2.54M	Buy	+41,400	New	+$2.86M	﹤0.01%	1963

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jim Simons's ARKG Position: Q1 2026 in Review

Jim Simons sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 67,700 shares — an estimated $1.96M sold.

Jim Simons first reported a position in ARKG in Q4 2021 and held it in 5 quarters. The position peaked at $2.65M in Q1 2022. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Jim Simons reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
Jim Simons sold 67,700 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $1.96M.
Jim Simons first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 5 quarters.
Jim Simons's ARK Genomic Revolution ETF position peaked at $2.65M in Q1 2022.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.